Investing in Japan
Latest UpdatesSuccess Story: Agilis GTRI Japan Inc.
Sep 12, 2017
Agilis Biotherapeutics, LLC, a US biotechnology company developing gene therapy, has established the joint venture Agilis GTRI Japan Inc., together with the Gene Therapy Research Institution Co., Ltd., a Japanese bio-venture company. In February 2017, Agilis GTRI Japan Inc. established a R&D center for gene therapy drug in Kawasaki, Japan. Its aim is to obtain Japan's first approval of gene therapy drugs for intractable central nervous system diseases such as AADC deficiency and Parkinson’s disease.
For more information about other cases, please see the Success Stories.